Very small embryonic-like stem cells (VSELs) isolated from bone marrow (BM) have been reported to be pluripotent. Given their nonembryonic source, they could replace blastocyst-derived embryonic stem cells in research and medicine. However, their multiple-germ-layer potential has been incompletely studied. Here, we show that we cannot find VSELs in mouse BM with any of the reported stem cell potentials, specifically for hematopoiesis. We found that: (1) most events within the ''VSEL'' flow-cytometry gate had little DNA and the cells corresponding to these events (2) could not form spheres, (3) did not express Oct4, and (4) could not differentiate into blood cells. These results provide a failure to confirm the existence of pluripotent VSELs.
INTRODUCTION
During normal development, pluripotent cells from the inner cell mass give rise to several types of tissue-committed stem cells (TSCs), restricted in their differentiation potential. TSCs can self-renew and produce downstream progenitors and mature cells throughout life. It remains controversial (Wagers et al., 2002; Wagers and Weissman, 2004) whether some pluripotent cells self-renew as pluripotent stem cells (PSCs) and persist after birth (Beltrami et al., 2007; Check, 2007; Jiang et al., 2002; Kögler et al., 2004; Krause et al., 2001; Serafini et al., 2007) .
One group has recently identified bone marrow (BM)-residing very small embryonic-like stem cells (VSELs) in both human and mouse as a putative nonembryonic source for PSCs (Druka1a et al., 2012; Kucia et al., 2006b; Wojakowski et al., 2009; Zuba-Surma et al., 2011) . Mouse VSELs have been characterized to: (1) be very small (3-5 mm), (2) have a CD45 À Lineage(Lin) À SCA-1 + phenotype, (3) express pluripotent marker genes (e.g., Oct4, Nanog), and (4) when cultured on the myoblast C2C12 cell line, form embryoid body-like spheres and then differentiate into multi-germ-layer cells. Moreover, these cells were reported to be directly obtainable from BM or mobilized peripheral blood without culture. Thus, their pluripotency should be reproducible in independent laboratories, a requirement for a scientific finding to be generally accepted (Jasny et al., 2011) . However, recent studies have shown the lack of stem cell characteristics in VSELs isolated from mouse (Szade et al., 2013) or human cord blood (CB) (Danova-Alt et al., 2012), while another study confirmed the existence of mouse VSELs and their ability to give rise to lung cells (Kassmer et al., 2013) . We sought to recapitulate the previous findings on relating to mouse VSELs, focusing on the DNA content of the small-sized fraction and on its hematopoietic lineage potential. We discovered an anomaly in separating cells by forward scatter (FSC) using different types of cell sorters and, more significantly, could not find PSCs within the VSEL fraction of mouse BM.
RESULTS

Identifying and Characterizing Candidate VSEL Cells
We sought to identify VSELs from mouse BM by using commonly reported VSEL characteristics (Kucia et al., 2006a; Ratajczak et al., 2011; Zuba-Surma et al., 2008) . We fractionated BM samples using fluorescence-activated cell sorting (FACS) . Dead cells and debris were excluded as Ratajczak and colleagues previously reported (ZubaSurma et al., 2008) . To minimize the risk of missing candidate cells, SCA-1 + cells (including SCA-1 lo ) beyond the threshold defined by the fluorescence minus one (FMO) method (Herzenberg et al., 2006) were included, and only the obvious Lin + cells were excluded from the Lin À fraction (which included Lin lo cells). Consequently, the Lin À SCA-1 + gate was more inclusive than that described elsewhere for VSELs and included all cells reported to be in the VSEL fraction (Kucia et al., 2006a; Ratajczak et al., 2008a Ratajczak et al., , 2011 . Lin À SCA-1 + events were subdivided into three fractions according to CD45 expression ( Figure 1A ; Table S1 available  online) . We used the FSC intensity of 10 mm microspheres to define the cutoff point between FSC lo and FSC hi events. As previously reported (Zuba-Surma et al., 2008) , the CD45 À fraction contained many more FSC lo cells than FSC hi cells.
Conversely, the CD45 hi fraction contained many more FSC hi cells than FSC lo cells ( Figure 1B ; Tables S1 and S2 ).
FSC lo events could include erythrocytes, vesicles, or cell fragments and/or debris. Since the original group has stated several times that VSELs are diploid Ratajczak et al., 2007 Ratajczak et al., , 2008b Figure 1C ). This indicated that our VSEL candidates were the relatively larger cells in the population analyzed, unlike the VSELs described in previous reports (Kucia et al., 2006a; Ratajczak et al., 2011; Wojakowski et al., 2009; Zuba-Surma et al., 2008 , and CD45 hi subfractions of Lin À SCA-1 + events. The mean ± SD of data from 22 independent experiments are shown. (C) Analysis of DNA content by SYTO16 staining. The threshold of high SYTO16 positivity was determined to include 99% of unfractionated BM cells (upper right). The vertical line in the lower plots indicates the position of 10 mm microspheres. See also Tables S1 and S2.
MoFlo (Beckman Coulter) (Zuba-Surma et al., 2008 ), but we used a FACSAria (BD Biosciences). Thus, we analyzed the same BM sample on a FACSAria and MoFlo. Based on the FSC intensity of unfractionated BM, 10 mm microspheres were positioned to the left of lymphocytes on the FACSAria but in between lymphocytes and granulocytes on the MoFlo (Figure 2A ). Using the FACSAria and the MoFlo, we sorted the BM sample into three subpopulations, based on the FSC intensity of defined-size microspheres. We then reanalyzed each of these subpopulations on both the FACSAria and MoFlo. Critically, a given population of cells seemed smaller (based on microsphere reference FSC intensities) on the MoFlo than on the FACSAria (Figures 2B and S1A). However, fluorescence intensity of the cell-to-cell comparison did not differ between the sorters ( Figure S1B ). Finally, we evaluated the FSC of candidate VSELs and hematopoietic stem/progenitor cells on FACSAria and MoFlo. Notably, more than 70% of candidate VSELs were detected in the FSC hi gate on FACSAria, whereas >80% of them were in the FSC lo gate on MoFlo ( Figure 2C ).
To address the concern that flow cytometer FSC based on microspheres is not a reliable indicator of absolute size, we 
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Failure to Detect VSEL in Mouse Bone Marrow measured the size of cells with an image flow cytometer (FlowSight, Amnis). We captured 2 3 10 6 BM cells and identified 34 events having the immunophenotype corresponding to the candidate VSELs ( Figure S1C ). Their mean diameter was nonsignificantly smaller than that of a randomly selected population of 100 CD45 hi Lin À SCA-1 + SYTO16 hi events (7.06 versus 7.51 mm; p = 0.82; Figure 2D ). However, only the candidate VSEL fraction contained few very small-sized (<5 mm) particles, as previously shown in fetal liver-resident VSELs cells at all ( Figure 3A ). These results contrast with previous reports (Kassmer et al., 2013; Kucia et al., 2006a; Ratajczak et al., 2011; Shin et al., 2010) . Next, we performed a sphere-forming assay using a mouse myoblastic C2C12 cell line Shin et al., 2010) . The C2C12 cell line is known to initiate its own differentiation and form muscle tubules when cultured in low serum concentrations (Yaffe and Saxel, 1977) . We observed that, when cultured alone, C2C12 cells aggregated spontaneously and sometimes formed spherelike structures ( Figure S2A ). Therefore, to distinguish 
Failure to Detect VSEL in Mouse Bone Marrow between spheres originating from candidate VSELs and spontaneous aggregation of C2C12 cells, we isolated candidate VSELs from Actin-EGFP transgenic mice and cocultured them with C2C12 cells. Some GFP + cells proliferated and formed small clusters ( Figure 3B ) but never the spheres described in previous reports Shin et al., 2010 and (2) methods of purification and functional analyses of hematopoietic stem cells (HSCs) have been established (Spangrude et al., 1988; Uchida and Weissman, 1992 Figure 4D , was similar to that described in a previous report (Hall et al., 2007 
DISCUSSION
The existence of pluripotent cells after the preimplantation blastocyst stage has not been demonstrated, except in the case of germline stem cells. Therefore, VSELs and other PSCs in postnatal mice must be independently verified to change how we view events in embryogenesis and fetal development. PSCs in postnatal humans, if they exist, would have an extremely significant impact on society because of their potential applications in research and regenerative medicine. In fact, the discovery of VSELs has already led to a commercial venture, Neostem, to bring their potential to human therapies. One of its financial backers, the Vatican, has announced in two symposia at the Vatican that these cells represent an ethical alternative to ESCs derived from humans (International Vatican Conference, November 9-11, 2011 and April 11-13, 2013, http://www.stemforlife.org/vatican-initiative).
In contrast to these optimistic findings, some groups have recently reported on their failure to detect VSELs. To accept a discovery as a scientific fact in the stem cell field, we previously proposed that all of the following three criteria are critical (Weissman, 2007) : (1) the initial discovery must be published in fully peer-reviewed journals; (2) the experiment as published must be repeatable in many independent laboratories; and (3) the phenomenon described should be so robust that other experimental methods must reveal it. And in the case of stem cells, the regeneration derived from their transplantation should be rapid, robust, and lifelong.
It is not infrequent that, although the initial findings are peer-reviewed, subsequent attempts to independently replicate the findings fail (Begley and Ellis, 2012) . We therefore sought to employ a logical strategy to examine all the cells within the CD45 À/int Lin À SCA-1 + population in mouse BM, even going as far as to include dead cells and cell debris in the analysis. Besides surface markers, the main criteria for the VSELs as defined by the original group are the following two points: (1) very small in size (3-5 mm) and (2) pluripotency. First, we tried to clarify whether this fraction contains any viable cells of the reported small size. We found that about 90% of all the events in this gate are indeed relatively small and have much less DNA than that of diploid cells according to SYTO16 staining measured on FACSAria ( Figure 1C ). This suggests that these relatively very small events are simply cell debris or fragments; subcellular particles, such as exosomes and blebs from dying cells, could be included. As mentioned above, it is unreliable to determine absolute cell size by FSC intensity (Figure 2 At the time of our writing this report, a few independent groups have replicated select aspects of VSEL: Bhartiya et al., 2012 reported VSEL-derived TSCs existed in mammalian ovary or in human BM and CB (Parte et al., 2011) and Sovalat et al. (2011) claimed VSELs could be isolated from human BM or granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood. However, all of these other groups evaluated only the existence of VSEL by the analysis of the cell size and immunophenotype without evaluating the pluripotency criteria, as criticized by the others in the field (Ivanovic, 2012) . In fact, other recent reports failed to detect the stem cell properties of mouse (Szade et al., 2013) or human VSELs (Danova-Alt et al., 2012) . When only one or a few markers of cells rather than the function of cells themselves are assayed, artifactual or nonphysiological expression of single markers can lead to the interpretation that a cell type rather than a marker is being studied. The only assays acceptable for functionally identifying stem cells are those that assess (1) self-renewal; (2) differentiation to clonal progeny of the cell types inferred from the name of the cell; and (3), for adult tissue outcomes, robust and sustained regeneration. The transfer of donor markers to host cells could occur by cell fusion and, theoretically, by exosome transfer, to the extent that exosomes are shown to be physiological entities and not cell culture artifacts.
We conclude that most CD45 À/int Lin À SCA-1 + cells in mouse BM were not as small as previously reported. Moreover, even despite broadening our search to include larger cells as candidates, we could not find a single instance of
proliferated to form spheres in cultures, or (3) demonstrated the ability to generate cells of the hematopoietic lineage-three functional aspects of pluripotency that were previously reported. These results suggest the absence of embryonic-like pluripotent cells in postnatal mouse BM. Additional rigorous data would be needed to demonstrate their existence both in humans and mouse before clinical application, including the derivation of the same repertoire of normal tissue cells currently demonstrated with ESC and/or induced pluripotent stem cells.
EXPERIMENTAL PROCEDURES
Mice
C57Bl/Ka-Thy1.2 Ly5.1 (B/Ka), C57Bl/Ka-Thy1.1 Ly5.1 (BA), C57Bl/Ka-Thy1.1 Ly5.1-Tg (actin-EGFP), and C57Bl/Ka-Thy1.1 Ly5.1-Tg (pH2K-BCL-2) mouse strains were derived and maintained in our laboratory. The Oct4-EGFP transgenic strain 
Cell Preparation and Staining
BM cells harvested from bilateral femurs and tibias with a flushing method were treated with BD Pharm Lyse Buffer (BD PharMingen). These cells were stained for 30 min with phycoerythrin (PE)-conjugated lineage antibodies (Lin), which consisted of anti-CD45R/ B220 (clone; RA3-6B2, final concentration; 4 mg/ml), anti-T cell receptor (TCR) b (H57-597, 4 mg/ml), anti-TCR gd (GL3, 4 mg/ml), anti-Ly-6G/C (RB6-8C5, 8 mg/ml), anti-CD11b (M1/70, 4 mg/ml), and anti-Ter119 (TER-119, 4 mg/ml); allophycocyanin-Cy7-conjugated anti-CD45 (30-F11, 8 mg/ml); and biotin-conjugated anti-Ly6A/E (SCA-1) (E13-161.7, 10 mg/ml) followed by streptavidin-PE-Cy5 (1 mg/ml). All the antibodies were purchased from BD. One micromolar SYTO16 (Life Technologies) was added to evaluate DNA quantity.
Flow Cytometry
Sorting and analyses were performed on multilaser-equipped FACSAria II and, where otherwise indicated, on a MoFlo cell sorter or FlowSight image flow cytometer. Dead cells were distinguished by adding 1 mM of SYTOX-Blue dead cell stain (Life Technologies).
To minimize contamination, a second round of sorting was performed. The automatic cell deposition system was used for single-cell assays. Data were analyzed with FlowJo software (Tree Star) or IDEAS software (Amnis). 
Isolation of HSCs and Candidate VSELs
OP9 Coculture Assay
OP9 coculture was performed as previously reported . OP9 cells were maintained in a-MEM (MEMa Nucleosides Powder, Life Technologies) with 10% FCS. Freshly isolated Lin /W 41 -recipient mice (Reith et al., 1990) , hematopoietic-deficient due to mutations in the W locus encoding the c-kit gene, received 400 cGy total body irradiation followed by intravenous injection of 100 sorted long-term HSCs via the retro-orbital vein. Peripheral blood and BM cells were analyzed by flow cytometry after transplantation to evaluate chimerism.
RNA Extraction and Real-Time RT-PCR
Prior to quantitative RT-PCR, 1 3 10 3 of each of the following cell types were sorted by flow cytometry: CD45 Table S2 .
Statistical Analysis
The nonparametric Mann-Whitney test was applied to all comparisons of mean values after F-test evaluation of variances. All statistical analyses were performed on Prism 5 software (GraphPad).
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